In January, after spending much of two years wrestling with trade issues, the U.S. signed two important pieces of legislation. The first, and likely more important, is the United States-Mexico-Canada Agreement, an update to NAFTA covering trade rules for North America. The second was a “Phase 1” agreement with China that reduced the likelihood of further tariff escalation and laid out a negotiating timeline to work through difficult discussions such as protection of intellectual property. The markets breathed a sigh of relief and began to rally on the thinking that businesses could now rely on (relative) certainty of trade and tariffs to support long-term product sourcing decisions.
Then along came the coronavirus (COVID-19). According to the World Health Organization, as of February 18, the virus has sickened more than 73,000 and killed 1,853. With most of these cases concentrated in the country of origin, China, the world has responded with various degrees of isolation. More than 30 airlines have suspended service to China and a 78-nation matrix of rules and quarantines from the U.S. to Singapore have all but banned Chinese travelers from foreign soil.
Read More